Alaunos Therapeutics Statistics
Total Valuation
TCRT has a market cap or net worth of $17.45 million. The enterprise value is $13.31 million.
| Market Cap | 17.45M |
| Enterprise Value | 13.31M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, before market open.
| Earnings Date | May 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TCRT has 16.01 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Shares Outstanding | 16.01M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 14.30% |
| Owned by Institutions (%) | 14.61% |
| Float | 13.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3,490.73 |
| Forward PS | n/a |
| PB Ratio | 3.64 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,661.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.87, with zero debt.
| Current Ratio | 4.87 |
| Quick Ratio | 3.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.07 |
Financial Efficiency
Return on equity (ROE) is -229.60% and return on invested capital (ROIC) is -549.05%.
| Return on Equity (ROE) | -229.60% |
| Return on Assets (ROA) | -173.70% |
| Return on Capital (ROIC) | -549.05% |
| Revenue Per Employee | $5,000 |
| Profits Per Employee | -$26.77M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.43% in the last 52 weeks. The beta is -0.26, so TCRT's price volatility has been lower than the market average.
| Beta (1Y) | -0.26 |
| 52-Week Price Change | -85.43% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 39.12 |
| Average Volume (30 Days) | 51,711 |
Short Selling Information
The latest short interest is 1.45 million, so 9.07% of the outstanding shares have been sold short.
| Short Interest | 1.45M |
| Short Previous Month | 1.47M |
| Short % of Shares Out | 9.07% |
| Short % of Float | 11.10% |
| Short Ratio (days to cover) | 28.42 |
Income Statement
In the last 12 months, TCRT had revenue of $5,000 and -$26.77 million in losses. Loss per share was -$1.86.
| Revenue | 5,000 |
| Gross Profit | 5,000 |
| Operating Income | -26.34M |
| Pretax Income | -26.77M |
| Net Income | -26.77M |
| EBITDA | -23.91M |
| EBIT | -25.71M |
| Loss Per Share | -$1.86 |
Balance Sheet
The company has $4.15 million in cash and no debt, giving a net cash position of $4.15 million or $0.26 per share.
| Cash & Cash Equivalents | 4.15M |
| Total Debt | n/a |
| Net Cash | 4.15M |
| Net Cash Per Share | $0.26 |
| Equity / Book Value | 4.80M |
| Book Value Per Share | 0.30 |
| Working Capital | 4.80M |
Cash Flow
In the last 12 months, operating cash flow was -$22.68 million and capital expenditures $1.37 million, giving a free cash flow of -$21.31 million.
| Operating Cash Flow | -22.68M |
| Capital Expenditures | 1.37M |
| Free Cash Flow | -21.31M |
| FCF Per Share | -$1.33 |
Margins
Gross margin is 100.00%, with operating and profit margins of -526,760.00% and -535,480.00%.
| Gross Margin | 100.00% |
| Operating Margin | -526,760.00% |
| Pretax Margin | -535,480.00% |
| Profit Margin | -535,480.00% |
| EBITDA Margin | -478,240.00% |
| EBIT Margin | -514,120.00% |
| FCF Margin | -426,180.00% |
Dividends & Yields
TCRT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.21% |
| Shareholder Yield | -0.21% |
| Earnings Yield | -153.40% |
| FCF Yield | -122.09% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 1, 2024. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
TCRT has an Altman Z-Score of -217.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -217.41 |
| Piotroski F-Score | 2 |